β Home
βΉοΈ Info
π§Ύ Overview π Core Facts π₯ Video Insights β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π’ Company Q&A π οΈ Industry Q&A π Competitors π Stock Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risks π§© Segmentationπ§ Tools
β Due DiligenceIncome Statement
Pay attention and research significant changes from year to year values. [ ! ]
Fixed Column | Revenue | Cost of Revenue | Gross Profit | Gross Profit Ratio | R&D Expenses | General And Administrative Expenses | Selling And Marketing Expenses | Selling General And Administrative Expenses | Other Expenses | Operating Expenses | Cost And Expenses | Interest Income | Interest Expense | Depreciation And Amortization | EBITDA | EBITDA Ratio | Operating Income | Operating Income Ratio | Total Other Income Expenses Net | Income Before Tax | Income Before Tax Ratio | Income Tax Expense | Net Income | Net Income Ratio | EPS | EPS Diluted | Weighted Average Shares Out | Weighted Average Shares Out Diluted |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-12 | 51722.0 | 12827.0 | 38895.0 | 0.0 | 10022.0 | 0.0 | 0.0 | 12566.0 | 1763.0 | 24351.0 | 37178.0 | 568.0 | 1006.0 | 6069.0 | 20715.0 | 0.4 | 14544.0 | 0.28 | -904.0 | 13640.0 | 0.26 | 1701.0 | 11941.0 | 0.23 | 5.97 | 5.87 | 1999.5 | 2035.0 |
2023-12 | 46660.0 | 12472.0 | 34188.0 | 0.0 | 11371.0 | 0.0 | 0.0 | 12489.0 | 559.0 | 24419.0 | 36891.0 | 627.0 | 855.0 | 8277.0 | 18286.0 | 0.39 | 9769.0 | 0.2 | -646.0 | 9123.0 | 0.19 | 551.0 | 14850.0 | 0.31 | 7.15 | 7.1 | 2076.79 | 2092.0 |
2022-12 | 51828.0 | 15486.0 | 36342.0 | 0.0 | 9996.0 | 0.0 | 0.0 | 14253.0 | 2896.0 | 27145.0 | 42631.0 | 379.0 | 837.0 | 6705.0 | 14726.0 | 0.31 | 9197.0 | 0.17 | 425.0 | 8371.0 | 0.16 | 1416.0 | 6955.0 | 0.13 | 3.19 | 3.17 | 2181.18 | 2197.0 |
2021-12 | 52877.0 | 15867.0 | 37010.0 | 0.0 | 9540.0 | 0.0 | 0.0 | 14886.0 | 895.0 | 25321.0 | 41188.0 | 71.0 | 811.0 | 5429.0 | 17132.0 | 0.62 | 26948.0 | 0.5 | -16150.0 | 26137.0 | 0.49 | 2119.0 | 24021.0 | 0.45 | 10.71 | 10.63 | 2242.6 | 2260.0 |
2020-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2019-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2018-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2017-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2016-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2015-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2014-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |

π Discover additional income statement data for Novartis!
Sign up for free or log inβ‘ Instantly access "The Checklist Value Investor β A Smarter Way to Pick Stocks" β free!